Views & Analysis What will the digital health ecosystem look like post-COVID? COVID-19 has turned the world on its head and healthcare systems have had to respond rapidly to match the sudden changes created by lockdown.
Views & Analysis New survey reveals patients’ changing opinions of pharma Exclusive research from WEGO Health has revealed patients’ changing attitudes towards the pharma industry and how they want to see companies improve.
Views & Analysis AstraZeneca on expanding its diabetes research franchise AstraZeneca is hoping to build a strong focus on cardiovascular, renal, and metabolic (CVRM) diseases.
Views & Analysis Could AI create a brave new world of pharma R&D? Barely a week goes by without one big pharma or biotech announcing that it is using AI to develop new medicines.
News Novartis raises forecasts for three key growth products Novartis raises sales expectations for three growth products – Kesimpta, Scemblix, and Leqvio – by $4bn as it sets a 5% midterm revenue growth target.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.